Literature DB >> 26275176

Brief Report: Doubly Robust Estimation of Standardized Risk Difference and Ratio in the Exposed Population.

Tomohiro Shinozaki1, Yutaka Matsuyama.   

Abstract

Standardization-a method used to adjust for confounding-estimates counterfactual risks in a target population. To adjust for confounding variables that contain too many combinations to be fully stratified, two model-based standardization methods exist: regression standardization and use of an inverse probability of exposure weighted-reweighted estimators. Whereas the former requires an outcome regression model conditional on exposure and confounders, the latter requires a propensity score model. In reconciling among their modeling assumptions, doubly robust estimators, which only require correct specification of either the outcome regression or the propensity score model but do not necessitate both, have been well studied for total populations. Here, we provide doubly robust estimators of standardized risk difference and ratio in the exposed population. Theoretical details, simple model extension for independently censored outcomes, and a SAS program are provided in the eAppendix (http://links.lww.com/EDE/A955).

Mesh:

Substances:

Year:  2015        PMID: 26275176     DOI: 10.1097/EDE.0000000000000363

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  3 in total

1.  Novel Longitudinal and Propensity Score Matched Analysis of Hands-On Cooking and Nutrition Education versus Traditional Clinical Education among 627 Medical Students.

Authors:  Dominique J Monlezun; Benjamin Leong; Esther Joo; Andrew G Birkhead; Leah Sarris; Timothy S Harlan
Journal:  Adv Prev Med       Date:  2015-09-08

2.  Understanding Marginal Structural Models for Time-Varying Exposures: Pitfalls and Tips.

Authors:  Tomohiro Shinozaki; Etsuji Suzuki
Journal:  J Epidemiol       Date:  2020-07-18       Impact factor: 3.211

3.  Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin.

Authors:  Takuya Kawahara; Tomohiro Shinozaki; Yutaka Matsuyama
Journal:  BMC Med Res Methodol       Date:  2020-07-31       Impact factor: 4.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.